dc.contributor.author |
Tachfouti, Nabil |
dc.contributor.author |
Najdi, Adil |
dc.contributor.author |
Alonso, Sergi |
dc.contributor.author |
Sicuri, Elisa |
dc.contributor.author |
Laamrani El Idrissi, Abderahmane |
dc.contributor.author |
Nejjari, Chakib |
dc.contributor.author |
Picado, Albert |
dc.date |
2016-07-18T07:58:38Z |
dc.date |
2016-07-18T07:58:38Z |
dc.date |
2016-06-03 |
dc.date |
2016-06-29T18:00:15Z |
dc.identifier.citation |
1932-6203 |
dc.identifier.uri |
http://hdl.handle.net/2445/100561 |
dc.format |
13 p. |
dc.format |
application/pdf |
dc.language.iso |
eng |
dc.publisher |
Public Library of Science (PLoS) |
dc.relation |
Reproducció del document publicat a:
http://dx.doi.org/10.1371/journal.pone.0155482 |
dc.relation |
PLoS One, 2016, vol. 11, num. 6, p. e0155482 |
dc.relation |
http://dx.doi.org/10.1371/journal.pone.0155482 |
dc.rights |
cc by (c) Tachfouti et al., 2016 |
dc.rights |
info:eu-repo/semantics/openAccess |
dc.rights |
http://creativecommons.org/licenses/by/3.0/es/ |
dc.subject |
Leishmaniosi |
dc.subject |
Infants |
dc.subject |
Marroc |
dc.subject |
Leishmaniasis |
dc.subject |
Children |
dc.subject |
Morocco |
dc.title |
Cost of Pediatric Visceral Leishmaniasis Care in Morocco |
dc.type |
info:eu-repo/semantics/article |
dc.type |
info:eu-repo/semantics/publishedVersion |
dc.description.abstract |
BACKGROUND: Visceral leishmaniasis (VL) is a neglected parasitic
disease that is fatal if left untreated. VL is endemic in
Morocco and other countries in North Africa were it mainly
affects children from rural areas. In Morocco, the direct
observation of Leishmania parasites in bone marrow aspirates and
serological tests are used to diagnose VL. Glucantime is the
first line of treatment. The objective of this study was to
report the costs associated to standard clinical management of
pediatric VL from the provider perspective in Morocco. As a
secondary objective we described the current clinical practices
and the epidemiological characteristics of pediatric VL
patients. METHODS: From March to June 2014 we conducted a survey
in eight hospitals treating pediatric VL patients in Morocco. A
pro-forma was used to collect demographic, clinical and
management data from medical records. We specifically collected
data on VL diagnosis and treatment. We also estimated the days
of hospitalization and the time to start VL treatment. Costs
were estimated by multiplying the use of resources in terms of
number of days in hospital, tests performed and drugs provided
by the official prices. For patients receiving part of their
treatment at Primary Health Centers (PHC) we estimated the cost
of administering the Glucantime as outpatient. We calculated the
median cost per VL patient. We also estimated the cost of
managing a VL case when different treatment strategies were
applied: inpatient and outpatient. RESULTS: We obtained data
from 127 VL patients. The median total cost per pediatric VL
case in Morocco is 520 US$. The cost in hospitals applying an
outpatient strategy is significantly lower (307 US$) than
hospitals keeping the patients for the whole treatment (636
US$). However the outpatient strategy is not yet recommended as
VL treatment for children in the Moroccan guidelines. VL
diagnosis and treatment regimens should be standardized
following the current guidelines in Morocco. |